CIK 0001671858
- Non-accelerated filer
- Smaller reporting company
ARS Pharmaceuticals, Inc.
Sign in to watch- Ticker
- SPRY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811489190
- Phone
- +1 858-771-9307
- Business address
- 11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Silverback Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-13 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,500 | $9.00 | $14K | 1,744,994 |
| 2024-03-13 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,300 | $9.00 | $12K | 2,047,199 |
| 2024-02-29 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −800 | $9.02 | $7K | 1,746,494 |
| 2024-02-29 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,982 | $9.01 | $18K | 2,048,499 |
| 2024-02-29 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −1,000 | $9.02 | $9K | 1,747,447 |
| 2024-02-29 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −800 | $9.02 | $7K | 1,746,494 |
| 2024-02-29 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −1,982 | $9.01 | $18K | 2,048,499 |
| 2024-02-29 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −1,000 | $9.02 | $9K | 1,747,447 |
| 2024-02-28 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −25,456 | $9.02 | $230K | 1,747,294 |
| 2024-02-28 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −49,019 | $9.02 | $442K | 2,050,481 |
| 2024-02-28 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −24,303 | $9.02 | $219K | 1,748,447 |
| 2024-02-28 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −25,456 | $9.02 | $230K | 1,747,294 |
| 2024-02-28 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −49,019 | $9.02 | $442K | 2,050,481 |
| 2024-02-28 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −24,303 | $9.02 | $219K | 1,748,447 |
| 2024-02-26 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −100 | $9.01 | $901 | 1,772,750 |
| 2024-02-26 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −500 | $9.01 | $5K | 2,099,500 |
| 2024-02-26 | Tanimoto Sarina CHIEF MEDICAL OFFICER | Sale 10b5-1 | −100 | $9.01 | $901 | 1,772,750 |
| 2024-02-26 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −100 | $9.01 | $901 | 1,772,750 |
| 2024-02-26 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −500 | $9.01 | $5K | 2,099,500 |
| 2024-02-26 | Lowenthal Richard E PRESIDENT AND CEO | Sale 10b5-1 | −100 | $9.01 | $901 | 1,772,750 |
Page 19 of 31 · 602 trades